Differential Effectiveness of Adjuvant Endocrine Therapy According to Menopausal Status, Body Mass Index, and Molecular Subtype in Hormone Receptor-Positive Breast Cancer.

Koh JH, Hong Y, Sim EJ, Sung S, Lim W, Lee HB, Moon HG, Han W, Park SK, Korean Breast Cancer Society

Open source

DOI
10.4048/jbc.2025.0109
Published
2026 Aug
Container
Journal of breast cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4048/jbc.2025.0109,
  title = {Differential Effectiveness of Adjuvant Endocrine Therapy According to Menopausal Status, Body Mass Index, and Molecular Subtype in Hormone Receptor-Positive Breast Cancer.},
  author = {Koh JH and Hong Y and Sim EJ and Sung S and Lim W and Lee HB and Moon HG and Han W and Park SK and Korean Breast Cancer Society},
  year = {2026},
  journal = {Journal of breast cancer},
  doi = {10.4048/jbc.2025.0109},
  url = {https://doi.org/10.4048/jbc.2025.0109}
}

RIS

TY  - JOUR
TI  - Differential Effectiveness of Adjuvant Endocrine Therapy According to Menopausal Status, Body Mass Index, and Molecular Subtype in Hormone Receptor-Positive Breast Cancer.
AU  - Koh JH
AU  - Hong Y
AU  - Sim EJ
AU  - Sung S
AU  - Lim W
AU  - Lee HB
AU  - Moon HG
AU  - Han W
AU  - Park SK
AU  - Korean Breast Cancer Society
PY  - 2026
JO  - Journal of breast cancer
DO  - 10.4048/jbc.2025.0109
UR  - https://doi.org/10.4048/jbc.2025.0109
ER  - 

APA

JH, K., Y, H., EJ, S., S, S., W, L., HB, L., HG, M., W, H., SK, P., & Society, K. B. C. (2026). Differential Effectiveness of Adjuvant Endocrine Therapy According to Menopausal Status, Body Mass Index, and Molecular Subtype in Hormone Receptor-Positive Breast Cancer.. Journal of breast cancer. https://doi.org/10.4048/jbc.2025.0109

Source records